IL-4 Licenses B Cell Activation Through Cholesterol Synthesis

Area of Science:

• Immunology
• Cell Biology
• Metabolic Regulation

Background:

• Lymphocyte activation transitions from catabolic metabolism to an anabolic state, similar to cancer cells, requiring increased nutrients for proliferation.
• Interleukin-4 (IL-4) is a key cytokine that supports B cell activation, but its precise mechanisms remain unclear.
• Understanding IL-4's role is crucial for deciphering immune responses and developing targeted therapies.

Approach:

• Utilized single-cell RNA sequencing to analyze gene expression changes in B cells following IL-4 signaling.
• Investigated the requirement of cholesterol biosynthesis for B cell activation in vivo and in vitro.
• Manipulated lipid availability to assess the impact on B cell endoplasmic reticulum expansion, cell cycle progression, and proliferation.

Key Points:

• IL-4 signaling transcriptionally upregulates the cholesterol biosynthetic program in early B cell responses.
• Cholesterol biosynthesis is essential for B cell activation and proliferation in vivo.
• Cholesterol is required for B cell endoplasmic reticulum expansion, cell cycle progression, and proliferation in vitro.

Conclusions:

• IL-4 acts as a B cell growth factor by rewiring lipid anabolic pathways, specifically cholesterol biosynthesis.
• This rewiring makes B cells less dependent on environmental nutrient availability for proliferation.
• The findings reveal a novel mechanism by which IL-4 supports B cell expansion and immune responses.